المؤلفون: Lv B; Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China., Li Y; Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China., Shi A; Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China., Pan J; Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Sep; Vol. 23 (9), pp. 1173-1181. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Databases, Factual* , Drug-Related Side Effects and Adverse Reactions*/epidemiology , Data Mining*/methods , Computer Simulation* , Product Surveillance, Postmarketing*/methods , Product Surveillance, Postmarketing*/statistics & numerical data, Humans ; Male ; Female ; United States ; United States Food and Drug Administration ; Sex Factors ; Odds Ratio ; Bias ; Drug Interactions ; Confounding Factors, Epidemiologic ; Models, Statistical

المؤلفون: Mooghali M; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Yale Collaboration for Regulatory Rigor, Integrity and Transparency, Yale School of Medicine, New Haven, Connecticut., Wallach JD; Yale Collaboration for Regulatory Rigor, Integrity and Transparency, Yale School of Medicine, New Haven, Connecticut.; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia., Ross JS; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Yale Collaboration for Regulatory Rigor, Integrity and Transparency, Yale School of Medicine, New Haven, Connecticut.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.; Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, Connecticut., Ramachandran R; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Yale Collaboration for Regulatory Rigor, Integrity and Transparency, Yale School of Medicine, New Haven, Connecticut.

المصدر: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2430486. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: United States Food and Drug Administration* , Drug Approval*/legislation & jurisprudence , Product Surveillance, Postmarketing*/methods , Product Surveillance, Postmarketing*/statistics & numerical data, United States ; Humans ; Cross-Sectional Studies ; Clinical Trials as Topic ; Endpoint Determination ; Biomarkers

المؤلفون: Hochreiter-Hufford A; Cook Research Incorporated, 1 Geddes Way, West Lafayette, IN, 47906, USA.; 3Aware, Indianapolis, IN, USA., Gatz J; Regenstrief Institute, Indianapolis, IN, USA., Griggs AM; Cook Research Incorporated, 1 Geddes Way, West Lafayette, IN, 47906, USA., Schoch RD; Cook Research Incorporated, 1 Geddes Way, West Lafayette, IN, 47906, USA., Birmingham KM; Cook Research Incorporated, 1 Geddes Way, West Lafayette, IN, 47906, USA., Frederick C; Regenstrief Institute, Indianapolis, IN, USA., Price J; Regenstrief Institute, Indianapolis, IN, USA., Snyder S; Cook Research Incorporated, 1 Geddes Way, West Lafayette, IN, 47906, USA. scott.snyder@cookmedical.com.

المصدر: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2024 Sep 19; Vol. 24 (1), pp. 263. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101088682 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6947 (Electronic) Linking ISSN: 14726947 NLM ISO Abbreviation: BMC Med Inform Decis Mak Subsets: MEDLINE

مواضيع طبية MeSH: Product Surveillance, Postmarketing* , Embolization, Therapeutic*/instrumentation , Embolization, Therapeutic*/standards, Humans ; Electronic Health Records/standards ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Indiana ; Adult ; Equipment Safety/standards

المؤلفون: Kajiyama K; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Regulatory Science Research, Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Komamine M; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Horiuchi N; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Iguchi T; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Uyama Y; Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

المصدر: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Sep; Vol. 33 (9), pp. e70007.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Product Surveillance, Postmarketing*, Humans ; Drug-Related Side Effects and Adverse Reactions/prevention & control ; Risk Assessment ; Pharmacoepidemiology ; Adverse Drug Reaction Reporting Systems/legislation & jurisprudence ; United States Food and Drug Administration ; United States

المؤلفون: Grant T; Team Consulting, Cambridge, United Kingdom tom.grant@team-consulting.com.

المصدر: PDA journal of pharmaceutical science and technology [PDA J Pharm Sci Technol] 2024 Aug 23; Vol. 78 (4), pp. 524-525. Date of Electronic Publication: 2024 Aug 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pda (Parenteral Drug Association) Country of Publication: United States NLM ID: 9439538 Publication Model: Electronic Cited Medium: Internet ISSN: 1948-2124 (Electronic) Linking ISSN: 10797440 NLM ISO Abbreviation: PDA J Pharm Sci Technol Subsets: MEDLINE

مواضيع طبية MeSH: Product Surveillance, Postmarketing*/methods, Humans ; Product Labeling/standards ; Equipment and Supplies/standards ; Equipment Design ; Internet

المؤلفون: Akagi T; Department of Cardiovascular Medicine, Okayama University Hospital., Hara H; Division of Cardiovascular Medicine, Toho University Ohashi Medical Center., Kanazawa H; Department of Cardiology, Keio University School of Medicine., Fukui S; Department of Cardiology, Fujita Health University., Hashimoto Y; Stroke Center, Saiseikai Kumamoto Hospital., Iguchi Y; Department of Neurology, The Jikei University School of Medicine., Iwama T; Gifu Municipal Hospital., Kataoka H; Department of Neurosurgery, National Cerebral and Cardiovascular Center., Kawamura A; Department of Cardiology, International University of Health and Welfare Narita Hospital., Kawano H; Department of Stroke and Cerebrovascular Medicine, Kyorin University., Oki K; Department of Neurology, Tokyo Saiseikai Central Hospital., Yamagami H; Department of Stroke Neurology, NHO Osaka National Hospital.

مؤلفون مشاركون: PFO Japan PMS Investigators

المصدر: Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2024 Aug 23; Vol. 88 (9), pp. 1391-1397. Date of Electronic Publication: 2024 May 11.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Japanese Circulation Society Country of Publication: Japan NLM ID: 101137683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-4820 (Electronic) Linking ISSN: 13469843 NLM ISO Abbreviation: Circ J Subsets: MEDLINE

مواضيع طبية MeSH: Foramen Ovale, Patent*/surgery , Product Surveillance, Postmarketing* , Septal Occluder Device*/adverse effects, Humans ; Japan ; Middle Aged ; Male ; Female ; Adult ; Aged ; Prospective Studies ; Treatment Outcome ; Cardiac Catheterization/adverse effects ; Cardiac Catheterization/instrumentation ; Time Factors

المؤلفون: Yu M; Department of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China., Zhou L; Department of Urology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China., Cao M; Department of Pharmacy, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China., Ji C; Department of Pharmacy, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Zheng Y; Department of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 20; Vol. 15, pp. 1397692. Date of Electronic Publication: 2024 Aug 20 (Print Publication: 2024).

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacovigilance* , Product Surveillance, Postmarketing* , Adverse Drug Reaction Reporting Systems* , Databases, Factual*, Humans ; Male ; Female ; Aged ; Middle Aged ; Adult ; United States/epidemiology ; Immunoconjugates/adverse effects ; Young Adult ; Antibodies, Monoclonal/adverse effects ; Adolescent ; Aged, 80 and over ; United States Food and Drug Administration ; Drug-Related Side Effects and Adverse Reactions/epidemiology

المؤلفون: Tanaka Y; First Department of Internal Medicine, Faculty of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Mizutani H; Post Marketing Study Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Fujii K; Post Marketing Study Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Okubo N; Biostatistics & Data Management Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.

المصدر: Modern rheumatology [Mod Rheumatol] 2024 Aug 20; Vol. 34 (5), pp. 927-935.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Denosumab*/adverse effects , Denosumab*/therapeutic use , Product Surveillance, Postmarketing* , Bone Density Conservation Agents*/therapeutic use , Bone Density Conservation Agents*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Aged ; Japan/epidemiology ; Treatment Outcome ; Prospective Studies ; Disease Progression ; Adult ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/adverse effects ; East Asian People

المؤلفون: Yoon H; Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea., Ye BD; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Kang SB; The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon, Korea., Lee KM; The Catholic University of Korea, ST. Vincent's Hospital, Suwon, Gyeonggi-do, Korea., Choi CH; Chung-Ang University College of Medicine, Seoul, Korea., Jo JY; Pfizer Pharmaceutical Korea Ltd, Seoul, Korea., Woo J; Pfizer Pharmaceutical Korea Ltd, Seoul, Korea., Cheon JH; Department of Internal Medicine, College of Medicine, Yonsei University, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea. geniushee@yuhs.ac.

المصدر: BMC gastroenterology [BMC Gastroenterol] 2024 Aug 19; Vol. 24 (1), pp. 273. Date of Electronic Publication: 2024 Aug 19.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Pyrimidines*/adverse effects , Pyrimidines*/therapeutic use , Pyrimidines*/administration & dosage , Piperidines*/adverse effects , Piperidines*/therapeutic use , Piperidines*/administration & dosage , Colitis, Ulcerative*/drug therapy , Product Surveillance, Postmarketing*, Humans ; Male ; Female ; Adult ; Prospective Studies ; Middle Aged ; Republic of Korea ; Pyrroles/adverse effects ; Pyrroles/therapeutic use ; Pyrroles/administration & dosage ; Treatment Outcome ; Janus Kinase Inhibitors/adverse effects ; Janus Kinase Inhibitors/therapeutic use ; Janus Kinase Inhibitors/administration & dosage ; Aged ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Young Adult ; Remission Induction

المؤلفون: Takahashi N; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan., Kondo T; Department of Hematology, Blood Disorders Center, Aiiku Hospital, Sapporo, Japan., Ikari Y; Department of Cardiology, Tokai University Hospital, Isehara, Japan., Fukumoto Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan., Hatake K; Department of Lymphoma/Hematology Center, Mita Hospital, International University of Health and Welfare, Tokyo, Japan., Masunari A; Otsuka Pharmaceutical Co., Ltd, Tokyo., Nishibayashi S; Otsuka Pharmaceutical Co., Ltd, Tokyo., Kageyama A; Otsuka Pharmaceutical Co., Ltd, Tokyo., Fukuta Y; Otsuka Pharmaceutical Co., Ltd, Tokyo., Tojo A; Tokyo Medical and Dental University, Tokyo, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Aug 14; Vol. 54 (8), pp. 930-938.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Imidazoles*/adverse effects , Imidazoles*/administration & dosage , Imidazoles*/therapeutic use , Pyridazines*/adverse effects , Pyridazines*/therapeutic use , Pyridazines*/administration & dosage , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Product Surveillance, Postmarketing* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Arterial Occlusive Diseases*/chemically induced , Arterial Occlusive Diseases*/epidemiology, Humans ; Male ; Female ; Middle Aged ; Aged ; Japan/epidemiology ; Adult ; Aged, 80 and over ; Young Adult ; Adolescent ; Treatment Outcome ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use